Abbott opened its new development labs and a pilot plant facility based in Ludwigshafen, Germany. The facility will research technologies and test large-scale production of newly developed drug formulations. The expansion is part of the company’s global drug delivery business, SOLIQS.     “Abbott is committed to advancing scientific innovation and bringing new medicines to patients,” said John M. Leonard, M.D., senior vice president, Pharmaceuticals, Research and Developmen...